"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"
PHASE2CompletedINTERVENTIONAL
Enrollment
29
Participants
Timeline
Start Date
August 31, 2000
Primary Completion Date
July 31, 2005
Study Completion Date
July 31, 2006
Conditions
Renal Transplant
Interventions
DRUG
Campath-1H
Trial Locations (1)
53792
University of Wisconsin, Madison
All Listed Sponsors
lead
University of Wisconsin, Madison
OTHER
NCT00365846 - "A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation" | Biotech Hunter | Biotech Hunter